Antibodies to Optic Nerve Glycosaminoglycans in Glaucoma

Martin Wax, MD
Washington University Medical Schoo (St. Louis, MO)
Year Awarded:
1999
Grant Duration:
April 1, 1999 to March 31, 2001
Disease:
Glaucoma
Award Amount:
$50,000
Grant Reference ID:
G1999016
Award Type:
Standard
Award Region:
US Midwestern

Antibodies to Optic Nerve Glycosaminoglycans in Glaucoma

Details


Although high intraocular pressure (IOP) is frequently associated with glaucoma, some people have the disease without high IOP. In these cases, it has been suggested that nerve death and damage to the optic nerve may result from a person's own antibodies (autoimmunity) that mistakenly attack the optic nerve and/or its blood supply. Dr. Wax has provided evidence that some glaucoma patients have antibodies that interact with important molecules (called glycosaminoglycans) that help form support structures for the optic nerve. He will now perform a detailed analysis to further characterize the specificity of these antibodies and determine whether there are changes in the glycosaminoglycans of patients with the antibodies. In addition, he will correlate the extent of antibody reactivity to glycosaminoglycans with optic nerve damage. The goal of this study is to confirm the hypothesis that autoimmunity plays a role in glaucoma.
Don't miss out.
Receive research updates, inspiring stories, and expert advice
Please enter your first name.
Please enter your last name.
Keep me informed about: *
Please select at least one.
You must select at least one disease category.